Major Boosts for Cell and Gene Therapy Sector

Published on: LinkedIn (Spencer Knight)

The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval for Papzimeos, the first therapy for recurrent respiratory papillomatosis. Anocca raised $46M to advance its TCR-T program for pancreatic cancer in Europe. Kriya Therapeutics secured $313M to expand its gene therapy pipeline across nine programs. Together, these advances highlight accelerating progress and investment in the sector.

👉 Read the full article: Huge Weekend for Cell and Gene Therapy

Disclaimer:

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.